Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Graves' Dysthyroid OphthalmopathyThyroid Related Orbitopathy

Interventions

DRUG

Rituximab

Trial Locations (2)

Simeon A. Lauer, MD, New York

Rona Z. Silkiss, MD, FACS, Oakland

All Listed Sponsors

collaborator

Lauer, Simeon, M.D.

UNKNOWN

collaborator

Reier, Alice M.D.

UNKNOWN

collaborator

Coleman, Morton M.D.

UNKNOWN

lead

Silkiss, Rona Z., M.D., FACS

INDIV

NCT00424151 - Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy | Biotech Hunter | Biotech Hunter